Boundless Bio Inc (BOLD)
9.93
-0.03
(-0.30%)
USD |
NASDAQ |
May 17, 16:00
9.93
0.00 (0.00%)
After-Hours: 19:24
Boundless Bio Shareholders Equity (Quarterly): -141.18M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -141.18M |
December 31, 2023 | -127.08M |
September 30, 2023 | -116.04M |
Date | Value |
---|---|
June 30, 2023 | -103.87M |
December 31, 2022 | -81.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-141.18M
Minimum
Mar 2024
-81.70M
Maximum
Dec 2022
-113.97M
Average
-116.04M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
Syra Health Corp | 3.449M |
Adlai Nortye Ltd | -317.54M |
CEL-SCI Corp | 12.65M |
AIM ImmunoTech Inc | 10.23M |
IGC Pharma Inc | 9.053M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 117.08M |
Total Liabilities (Quarterly) | 258.26M |